We strive for a modern diagnostics experience, suitable for today’s at-home medical revolution, accessible for all and easy to use. Our novel platform can accurately detect multiple pathogens and genetic biomarkers from a single sample. It can reduce diagnosis time-to-results from days to minutes. Our proprietary technology offers PCR grade accuracy with rapid home testing conveniency, enabling an end-to-end solution for diagnosis of bacterial and viral infections anywhere and anytime.
Company Details
- Employees
- 7
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Kanso Diagnostics Questions
Kanso Diagnostics's LinkedIn profile is https://www.linkedin.com/company/kanso-diagnostics
Kanso Diagnostics has
7 employees.
View email and phone details for 7
employees at Kanso Diagnostics.
Kanso Diagnostics's industry is
Biotechnology Research
Kanso Diagnostics's top competitors are
Immunai,
Peregrine Ventures,
Cytoreason,
Biomx (Nyse: Phge),
Compugen,
Clika Inc.,
Catchme Therapeutics,
Adversa Ai,
Hirundo,
Futurx.
Kanso Diagnostics's categories are Biotechnology Research
Kanso Diagnostics's founding year is 2022
